OTC Obesity - Ukraine
In 2009, OTC obesity sales decreased by 5% in current value terms. The only brand present is Xenical, which was not supported with TV advertising and posters in drugstores and pharmacies in 2009, whilst in 2008 it was. Due to the devaluation of the local currency, retail prices in 2009 increased by 36% compared to 2008. High unit prices and the economic downturn had a negative impact on the demand. The demand for Xenical is seasonal; the highest demand is over autumn, winter and spring,...
Euromonitor International's OTC Obesity Products in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's OTC Obesity Products in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
OTC Obesity in Ukraine
Euromonitor International
May 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Ukrainian Consumer Healthcare Continues To Grow Due To Rising Prices and Demand
Legal Regulation Has Significantly Affected OTC Medicines
Interest in Ukrainian Market Is High Amongst Foreign Companies
Chemists/pharmacies Remains Main Retail Channel
Macroeconomic Conditions and Changes To Legislation Will Significantly Determine the Dynamics of Market Development
Key Trends and Developments
the Economic Crisis Changed Consumers' Buying Habits
Changing Channels of Distribution
Government Stepped Up Regulation of Consumer Healthcare
Despite the Economic Crisis, the Number of Births Increased in 2009
Ukrainian Women Turn To Traditional Herbal Methods As Well As Homoeopathy
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Definitions
Sources
Summary 1 Research Sources
Arterium Corp
Strategic Direction
Key Facts
Summary 2 Arterium Corp: Key Facts
Summary 3 Arterium Corp: Operational Indicators 2007-2009
Company Background
Production
Summary 4 Arterium Corp: Production Statistics 2008
Competitive Positioning
Summary 5 Arterium Corp: Competitive Position 2009
Borschahivsky Hfz Zat
Strategic Direction
Key Facts
Summary 6 Borschahivsky HFZ ZAT: Key Facts
Summary 7 Borschahivsky HFZ ZAT: Operational Indicators 2007-2009
Company Background
Production
Summary 8 Borschahivsky HFZ ZAT: Production Statistics 2008
Competitive Positioning
Summary 9 Borschahivsky HFZ ZAT: Competitive Position 2009
Darnitsa Ff Zat
Strategic Direction
Key Facts
Summary 10 Darnitsa FF ZAT: Key Facts
Summary 11 Darnitsa FF ZAT: Operational Indicators 2007-2009
Company Background
Production
Summary 12 Darnitsa FF ZAT: Production Statistics 2008
Competitive Positioning
Summary 13 Darnitsa FF ZAT: Competitive Position 2009
Farmak Vat
Strategic Direction
Key Facts
Summary 14 Farmak VAT: Key Facts
Summary 15 Farmak VAT: Operational Indicators 2007-2009
Company Background
Production
Summary 16 Farmak VAT: Production Statistics 2009
Competitive Positioning
Summary 17 Farmak VAT: Competitive Position 2009
Zdorovya Fk Tov
Strategic Direction
Key Facts
Summary 18 Zdorovya FK TOV: Key Facts
Summary 19 Zdorovya FK TOV: Operational Indicators 2007-2009
Company Background
Production
Summary 20 Zdorovya FK TOV: Production Statistics 2009
Competitive Positioning
Summary 21 Zdorovya FK TOV: Competitive Position 2009
Trends
Category Data
Table 11 Sales of OTC Obesity: Value 2006-2009
Table 12 Sales of OTC Obesity: % Value Growth 2006-2009
Table 13 OTC Obesity Company Shares by Value 2005-2009
Table 14 OTC Obesity Brand Shares by Value 2006-2009
Table 15 Forecast Sales of OTC Obesity: Value 2009-2014
Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014
Euromonitor International
May 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Ukrainian Consumer Healthcare Continues To Grow Due To Rising Prices and Demand
Legal Regulation Has Significantly Affected OTC Medicines
Interest in Ukrainian Market Is High Amongst Foreign Companies
Chemists/pharmacies Remains Main Retail Channel
Macroeconomic Conditions and Changes To Legislation Will Significantly Determine the Dynamics of Market Development
Key Trends and Developments
the Economic Crisis Changed Consumers' Buying Habits
Changing Channels of Distribution
Government Stepped Up Regulation of Consumer Healthcare
Despite the Economic Crisis, the Number of Births Increased in 2009
Ukrainian Women Turn To Traditional Herbal Methods As Well As Homoeopathy
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Definitions
Sources
Summary 1 Research Sources
Arterium Corp
Strategic Direction
Key Facts
Summary 2 Arterium Corp: Key Facts
Summary 3 Arterium Corp: Operational Indicators 2007-2009
Company Background
Production
Summary 4 Arterium Corp: Production Statistics 2008
Competitive Positioning
Summary 5 Arterium Corp: Competitive Position 2009
Borschahivsky Hfz Zat
Strategic Direction
Key Facts
Summary 6 Borschahivsky HFZ ZAT: Key Facts
Summary 7 Borschahivsky HFZ ZAT: Operational Indicators 2007-2009
Company Background
Production
Summary 8 Borschahivsky HFZ ZAT: Production Statistics 2008
Competitive Positioning
Summary 9 Borschahivsky HFZ ZAT: Competitive Position 2009
Darnitsa Ff Zat
Strategic Direction
Key Facts
Summary 10 Darnitsa FF ZAT: Key Facts
Summary 11 Darnitsa FF ZAT: Operational Indicators 2007-2009
Company Background
Production
Summary 12 Darnitsa FF ZAT: Production Statistics 2008
Competitive Positioning
Summary 13 Darnitsa FF ZAT: Competitive Position 2009
Farmak Vat
Strategic Direction
Key Facts
Summary 14 Farmak VAT: Key Facts
Summary 15 Farmak VAT: Operational Indicators 2007-2009
Company Background
Production
Summary 16 Farmak VAT: Production Statistics 2009
Competitive Positioning
Summary 17 Farmak VAT: Competitive Position 2009
Zdorovya Fk Tov
Strategic Direction
Key Facts
Summary 18 Zdorovya FK TOV: Key Facts
Summary 19 Zdorovya FK TOV: Operational Indicators 2007-2009
Company Background
Production
Summary 20 Zdorovya FK TOV: Production Statistics 2009
Competitive Positioning
Summary 21 Zdorovya FK TOV: Competitive Position 2009
Trends
Category Data
Table 11 Sales of OTC Obesity: Value 2006-2009
Table 12 Sales of OTC Obesity: % Value Growth 2006-2009
Table 13 OTC Obesity Company Shares by Value 2005-2009
Table 14 OTC Obesity Brand Shares by Value 2006-2009
Table 15 Forecast Sales of OTC Obesity: Value 2009-2014
Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014
